Evotec (OTCMKTS:EVTCY) Stock Price Passes Above 50-Day Moving Average - Time to Sell?

Key Points

• Technical move: Evotec crossed above its 50-day moving average of $2.86, trading as high as $3.20 (last trade $3.20) and rising about 2.6% on volume of 32,161 shares, though it remains just below the 200-day MA of $3.23.
• Fundamental snapshot: Market cap about $1.06 billion with a P/E of 7.81, a beta near 1.0, solid liquidity (quick ratio 2.50, current ratio 2.57) and modest leverage (debt-to-equity 0.53).

Evotec SE (OTCMKTS:EVTCY - Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $2.86 and traded as high as $3.20. Evotec shares last traded at $3.20, with a volume of 32,161 shares changing hands.

Evotec Stock Up 2.6%

The company has a market cap of $1.06 billion, a P/E ratio of 7.81 and a beta of 0.98. The stock has a 50-day moving average of $2.86 and a two-hundred day moving average of $3.23. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.

Evotec Company Profile

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company's platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.